Cargando…
Practical Considerations for the Use of Subcutaneous Treatment in the Management of Dyslipidaemia
Suboptimal drug adherence represents a major challenge to effective primary and secondary prevention of cardiovascular disease. While adherence is influenced by multiple considerations, polypharmacy and dosing frequency appear to be rate-limiting factors in patient satisfaction and subsequent adhere...
Autores principales: | Boccara, Franck, Dent, Ricardo, Ruilope, Luis, Valensi, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565663/ https://www.ncbi.nlm.nih.gov/pubmed/28717862 http://dx.doi.org/10.1007/s12325-017-0586-8 |
Ejemplares similares
-
Treatment of Dyslipidaemia in Children
por: Fiorentino, Riccardo, et al.
Publicado: (2021) -
Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice
por: Penson, Peter E., et al.
Publicado: (2021) -
HIV: how to manage dyslipidaemia in HIV
por: Lee, Daniel
Publicado: (2022) -
Established and Emerging Approaches for the Management of Dyslipidaemia
por: Norata, Giuseppe Danilo
Publicado: (2012) -
Diabetic dyslipidaemia
por: C. Thambiah, Subashini, et al.
Publicado: (2021)